close 76% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 76% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Dashboard

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Avatud

22.49 1.63

Osta

Hinna uuendus 1. aug 2025, 16:22 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.8

Max

22.74

Põhinäitajad

By Trading Economics

Sissetulek

-58M

-51M

Müük

-19M

10M

Kasumimarginaal

-486.444

Töötajad

61

EBITDA

-58M

-41M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+334.07% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. aug 2025

Turustatistika

By TradingEconomics

Turukapital

409M

Eelmine avamishind

20.86

Eelmine sulgemishind

22.49

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. juuli 2025, 23:56 UTC

Kuumad aktsiad

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

DJ

Loe

31. juuli 2025, 23:48 UTC

Market Talk

Scentre Can Beat Annual Earnings Guidance -- Market Talk

DJ

Loe

31. juuli 2025, 23:45 UTC

Market Talk

Nikkei May Decline Amid Caution Over Earnings, Domestic Politics -- Market Talk

DJ

Loe

31. juuli 2025, 23:37 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Loe

31. juuli 2025, 23:37 UTC

Market Talk

Gold Steady as Traders Eye Tariff-Deal Developments -- Market Talk

DJ

Loe

31. juuli 2025, 23:12 UTC

Tulu

OCBC: Evolving Trade, Monetary Policies, Persistent Geopolitical Tensions Expected to Weigh on Growth Prospects >O39.SG

DJ

Loe

31. juuli 2025, 23:10 UTC

Tulu

Oversea-Chinese Banking: Declining Interest-Rate Environment Weighed in Net Interest Income >O39.SG

DJ

Loe

31. juuli 2025, 23:09 UTC

Tulu

Oversea-Chinese Banking 2Q Net Interest Income S$2.28B Vs. S$2.43B >O39.SG

DJ

Loe

31. juuli 2025, 23:08 UTC

Tulu

Oversea-Chinese Banking 2Q Total Income S$3.55B Vs. S$3.63B >O39.SG

DJ

Loe

31. juuli 2025, 23:08 UTC

Tulu

Oversea-Chinese Banking 2Q Net S$1.82B Vs. Net S$1.94B >O39.SG

DJ

Loe

31. juuli 2025, 23:01 UTC

Tulu

Amazon Posts Higher Sales, Profit -- 3rd Update

DJ

Loe

31. juuli 2025, 22:08 UTC

Market Talk
Tulu

Amazon CEO Impressed by Deals Signed for Project Kuiper -- Market Talk

DJ

Loe

31. juuli 2025, 22:02 UTC

Market Talk
Tulu

Apple's FY Outlook Shows Sales Growth Won't Last -- Market Talk

DJ

Loe

31. juuli 2025, 21:57 UTC

Market Talk
Tulu

Amazon CEO Sees Strong Early Demand for Alexa+ -- Market Talk

DJ

Loe

31. juuli 2025, 21:50 UTC

Tulu

Amazon Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

DJ

Loe

31. juuli 2025, 21:43 UTC

Tulu

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- 2nd Update

DJ

Loe

31. juuli 2025, 21:29 UTC

Tulu

Amazon to Invest More in Chips, Data Centers Amid Generative AI Opportunity, CFO Says

DJ

Loe

31. juuli 2025, 21:26 UTC

Tulu

Apple Expects Revenue to Grow in Mid- to High-Single Digits in Current Quarter, CFO Says

DJ

Loe

31. juuli 2025, 21:26 UTC

Tulu

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

DJ

Loe

31. juuli 2025, 21:22 UTC

Tulu

Amazon Has Impressive Amount of Agreements for Project Kuiper, CEO Says

DJ

Loe

31. juuli 2025, 21:19 UTC

Tulu

Apple Estimates Tariff Impact to Add $1.1B to Costs in Current Quarter, CEO Says

DJ

Loe

31. juuli 2025, 21:19 UTC

Tulu

Apple Incurred $800M in Tariff-Related Costs in 2Q, CEO Says

DJ

Loe

31. juuli 2025, 21:14 UTC

Tulu

Amazon's AWS is Seeing More Demand Than Supply, CEO Says

DJ

Loe

31. juuli 2025, 21:12 UTC

Tulu

Amazon Saw Record Prime Sign-Ups in 3 Weeks Before Prime Day, CEO Says

DJ

Loe

31. juuli 2025, 21:10 UTC

Tulu

Amazon Just Getting Started on Automation, Robotics to Boost Efficiency, CEO Says

DJ

Loe

31. juuli 2025, 21:09 UTC

Tulu

Amazon Delivered to Prime Members at Record Pace in 2Q, CEO Says

DJ

Loe

31. juuli 2025, 21:09 UTC

Tulu

Amazon CEO Sees Diversity of Sellers as Advantage for Inflation-Weary Consumers

DJ

Loe

31. juuli 2025, 21:08 UTC

Tulu

Apple iPhone Revenue Performance Driven by Popularity of iPhone 16 Family, CEO Says

DJ

Loe

31. juuli 2025, 21:08 UTC

Tulu

Amazon CEO Sees Strong Customer Adoption of Perishables Same-Day Delivery Pilot

DJ

Loe

31. juuli 2025, 21:05 UTC

Tulu

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- Update

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

334.07% tõus

12 kuu keskmine prognoos

Keskmine 95.8 USD  334.07%

Kõrge 120 USD

Madal 69 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

7 ratings

5

Osta

1

Hoia

1

Müü

Põhineb 7 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

JNJ

Johnson and Johnson

167.25

↑ +1.51%

NVS

Novartis AG

115.07

↑ +1.29%

ABT

Abbott Laboratories

127.38

↑ +0.96%

TMO

Thermo Fisher Scientific Inc

462.78

↓-1.04%

ISRG

Intuitive Surgical Inc

483.28

↑ +0.46%